Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow enVVeno Medical Corp

Get SEC filing alerts via email and in your feed for enVVeno Medical Corp

NVNO NVNBW

enVVeno Medical Corp

About enVVeno Medical Corp

enVVeno Medical Corporation is a late-stage medical device company developing bioprosthetic solutions for venous disease, primarily focusing on chronic venous insufficiency. Its flagship products, VenoValve and enVVe, are designed as surgical and non-surgical venous valves to treat severe deep venous conditions. The company aims to improve patient outcomes and reduce healthcare costs through innovative, tissue-based implantable devices targeting a large, underserved market.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from enVVeno Medical Corp

1
1
enVVeno Medical Corp enVVeno Medical Reports $3.8 Million Net Loss in Q1 2026, Advances enVVe System

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
enVVeno Medical Corp enVVeno Medical Reports $19.5 Million Net Loss for Fiscal Year 2025, Focuses on enVVe System

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
enVVeno Medical Corp enVVeno Medical Reports $4.5 Million Net Loss in Q3 2025, Focuses on VenoValve Development

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
enVVeno Medical Corp enVVeno Medical Reports $6.7 Million Net Loss in Q2 2025, Increased Operating Expenses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
enVVeno Medical Corp enVVeno Medical Reports $4.5 Million Net Loss in Q1 2025, Focuses on VenoValve Development

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
enVVeno Medical Corp enVVeno Medical Reports $21.8 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
enVVeno Medical Corp enVVeno Medical Corporation Reports Q3 2024 Financial Results, Cash Position and Operational Updates

Via official filing (AI summary) | over 1 year ago | 0 comments